Incretin-based therapy and pancreatitis-what is the risk? - Suppr | 超能文献

Incretin-based therapy and pancreatitis-what is the risk?

作者信息

Sternthal Elliot

出版信息

Endocr Pract. 2011 May-Jun;17(3):334-6. doi: 10.4158/EP11126.ED.

DOI:10.4158/EP11126.ED

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Incretin-based therapy and pancreatitis-what is the risk?

Endocr Pract. 2011 May-Jun;17(3):334-6. doi: 10.4158/EP11126.ED.

2

Vildagliptin-induced acute pancreatitis.维格列汀致急性胰腺炎。

Endocr Pract. 2011 May-Jun;17(3):e48-50. doi: 10.4158/EP10383.CR.

3

Acute necrotizing pancreatitis associated with vildagliptin.与维格列汀相关的急性坏死性胰腺炎。

JOP. 2013 Jan 10;14(1):81-4. doi: 10.6092/1590-8577/1203.

4

Vildagliptin-induced acute pancreatitis without enzyme elevation.维格列汀诱发的急性胰腺炎，淀粉酶未升高

Turk J Gastroenterol. 2017 Nov;28(6):514-517. doi: 10.5152/tjg.2017.17308. Epub 2017 Oct 25.

5

Studies in rodents with the dipeptidyl peptidase-4 inhibitor vildagliptin to evaluate possible drug-induced pancreatic histological changes that are predictive of pancreatitis and cancer development in man.在啮齿类动物中进行的二肽基肽酶-4 抑制剂维达列汀研究，以评估可能导致胰腺炎和人类癌症发展的药物诱导的胰腺组织学变化。

Diabetes Obes Metab. 2013 Jan;15(1):72-6. doi: 10.1111/j.1463-1326.2012.01678.x. Epub 2012 Sep 9.

6

[Case report; suspected DPP-4 inhibitor-induced dropped head syndrome].[病例报告；疑似二肽基肽酶-4抑制剂诱发的垂头综合征]

Nihon Naika Gakkai Zasshi. 2013 Jun 10;102(6):1464-6. doi: 10.2169/naika.102.1464.

7

Vildagliptin monotherapy. To be avoided, like other DPP-4 inhibitors.维格列汀单药治疗。与其他二肽基肽酶-4抑制剂一样，应避免使用。

Prescrire Int. 2013 May;22(138):121.

8

Update: vildagliptin for the treatment of Type 2 diabetes.最新消息：维格列汀用于治疗2型糖尿病。

Expert Opin Investig Drugs. 2008 Jan;17(1):105-13. doi: 10.1517/13543784.17.1.105.

9

Pancreatitis with pancreatic tail swelling associated with incretin-based therapies detected radiologically in two cases of diabetic patients with end-stage renal disease.在两例终末期肾病糖尿病患者中，经放射学检查发现，基于肠促胰岛素的治疗与胰腺尾部肿胀相关的胰腺炎。

Intern Med. 2012;51(21):3045-9. doi: 10.2169/internalmedicine.51.7876. Epub 2012 Nov 1.

10

Evaluation of pharmacokinetic interactions between vildagliptin and digoxin in healthy volunteers.健康志愿者中维格列汀与地高辛药代动力学相互作用的评估。

J Clin Pharmacol. 2007 Aug;47(8):998-1004. doi: 10.1177/0091270007301802.

引用本文的文献

1

Metabolic Surgery for Type 2 Diabetes in Patients with a BMI of <35 kg/m(2): A Surgeon's Perspective.代谢手术治疗 BMI<35kg/m² 的 2 型糖尿病患者：外科医生视角。

Obes Surg. 2013 Jun;23(6):809-18. doi: 10.1007/s11695-013-0930-2.